Add BrightSurf on Google Email

Infectious Diseases Society of America


Experts call for strategies to address public health crisis of opioid, ID epidemics

The article highlights the growing public health crisis of opioid and infectious disease (ID) epidemics, citing increased rates of HIV, viral hepatitis, and skin infections linked to rising opioid use. Experts recommend strengthened responses by infectious diseases and substance use specialists, including investments in evidence-based ...

SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateApr 4, 2019

Cancer patients face higher risk for shingles, new vaccines hold promise for prevention

A new study found that cancer patients, particularly those with blood-related cancers, have a significantly higher risk of developing shingles due to the virus reactivating later in life. New shingles vaccines offer great promise as a strategy to prevent shingles and its complications in cancer patients.

SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateDec 13, 2018

ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy

The Infectious Diseases Society of America (IDSA) has released new guidelines for outpatient parenteral antimicrobial therapy (OPAT), emphasizing the importance of review by an infectious diseases specialist before starting treatment. Regular monitoring and blood tests are also recommended to ensure patient safety.

SourceInfectious Diseases Society of America·JournalClinical Infectious Diseases·DateNov 13, 2018

Societies recommend policies to retain, increase ranks of ID physician scientists

Challenges facing ID physician scientists include inadequate funding for fellowship opportunities and steep compensation disparities, leading to a decline in trainees pursuing careers as physician researchers. To address this, medical societies recommend expanded mentorship, training opportunities, and workforce diversity measures.

SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateAug 14, 2018

For patients with drug-resistant infections, infectious diseases experts may be lifesaving

A study published in Open Forum Infectious Diseases found that patients with drug-resistant infections who received consultation from ID specialists had a 50% lower 30-day mortality rate. ID consultation was also associated with reduced mortality and hospital readmissions for certain types of resistant bacteria.

SourceInfectious Diseases Society of America·JournalOpen Forum Infectious Diseases·DateMar 23, 2018

HPV vaccine also prevents uncommon childhood respiratory disease, study suggests

A recent study published in The Journal of Infectious Diseases found that Australia's highly successful HPV vaccination program has led to a significant decline in cases of recurrent respiratory papillomatosis, an uncommon and difficult-to-treat childhood respiratory disease. As a result, medical costs related to the disease have decre...

SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateNov 9, 2017

Outpatient antibiotics raise risk for acquiring C. difficile infection in the community

A new study confirms outpatient antibiotic use is a primary risk factor for acquiring C. difficile infection in the community, and recent emergency department visits may also pose a risk. The study found that patients with community-associated C. difficile infections were more likely to have prior health care visits and taken antibiotics.

SourceInfectious Diseases Society of America·JournalOpen Forum Infectious Diseases·DateOct 26, 2017

IDSA Infectious Diarrhea guidelines recommend when to test, when to treat

New culture-independent tests are more sensitive than traditional methods in detecting the cause of infectious diarrhea. However, these tests may detect multiple organisms, requiring infectious disease expertise for interpretation. The IDSA guidelines recommend testing children under 5, elderly individuals, and those with specific symp...

SourceInfectious Diseases Society of America·JournalClinical Infectious Diseases·DateOct 19, 2017

Common pain relievers may increase heart attack risk during respiratory infections

A new study suggests that widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness. Researchers found a stronger association with a heart attack when both an acute respiratory infection and NSAID use were present, with a 3.4-fold increased risk for a heart attack.

SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateFeb 2, 2017

Study finds heart infections increasing among younger injection drug users

A new study published in Open Forum Infectious Diseases found an increasing proportion of hospitalizations for infective endocarditis linked to injection drug use among younger patients, including more white and female individuals. The study suggests a growing need for programs and services to prevent these deadly and costly infections.

SourceInfectious Diseases Society of America·JournalOpen Forum Infectious Diseases·DateSep 1, 2016

Valley fever diagnosis often missed

Valley fever, caused by Coccidioides immitis and Coccidioides posadasii, affects over 150,000 people annually. Early diagnosis is crucial to prevent unnecessary tests and treatment, reducing the impact of complications. Pregnant women, immunocompromised individuals, and those with diabetes are at high risk for severe outcomes.

SourceInfectious Diseases Society of America·JournalClinical Infectious Diseases·DateJul 28, 2016

New guidelines OK less antibiotics for hospital-acquired, ventilator-associated pneumonia

The Infectious Diseases Society of America and American Thoracic Society recommend a 7-day or fewer antibiotic course for most hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) infections. Hospitals should create antibiograms to determine causative strains and ensure effective treatment.

SourceInfectious Diseases Society of America·JournalClinical Infectious Diseases·DateJul 18, 2016

For pregnant women with flu, the earlier the better for antiviral treatment

A new study published in The Journal of Infectious Diseases found that early treatment with the influenza antiviral drug oseltamivir can shorten the time a pregnant woman spends in the hospital, especially for those with severe illness. Annual flu vaccination is also crucial to prevent complications and protect the newborn baby.

SourceInfectious Diseases Society of America·JournalThe Journal of Infectious Diseases·DateFeb 4, 2016